Literature DB >> 11786377

Arachidonic acid release from rat Leydig cells: the involvement of G protein, phospholipase A2 and regulation of cAMP production.

A M Ronco1, P F Moraga, M N Llanos.   

Abstract

We have previously demonstrated that the release of arachidonic acid (AA) from human chorionic gonadotropin (hCG)-stimulated Leydig cells occurs in a dose- and time-dependent manner. In addition, the amount of AA released was dependent on the hormone-receptor interaction and the concentration of LH-hCG binding sites on the cell surface. The present study was conducted to evaluate the involvement of phospholipase A(2) (PLA(2)) and G proteins in AA release from hormonally stimulated rat Leydig cells, and the possible role of this fatty acid in cAMP production. Cells were first prelabelled with [(14)C]AA to incorporate the fatty acid into cell phospholipids, and then treated in different ways to evaluate AA release. hCG (25 mIU) increased the release of AA to 180+/-12% when compared with AA released from control cells, arbitrarily set as 100%. Mepacrine and parabromophenacyl bromide (pBpB), two PLA(2) inhibitors, decreased the hormone-stimulated AA release to 85+/-9 and 70+/-24% respectively. Conversely, melittin, a PLA(2) stimulator, increased the release of AA up to 200% over control. The inhibitory effect of mepacrine on the release of AA was evident in hCG-treated Leydig cells, but not in the melittin-treated cells. To determine if the release of AA was also mediated through a G protein, cells were first permeabilized and subsequently treated with pertussis toxin or GTPgammaS, a non-hydrolyzable analog of GTP. Results demonstrate that GTPgammaS was able to induce a similar level of the release of AA as hCG. In addition, pertussis toxin completely abolished the stimulatory effect of hCG on the release of AA, indicating that a member of the G(i) family was involved in the hCG-dependent release of AA. Cells treated with PLA(2) inhibitors did not modify cAMP production, but exogenously added AA significantly reduced cAMP production from hCG-treated Leydig cells, in a manner dependent on the concentration of AA and hCG. Results presented here suggest an involvement of PLA(2) and G proteins in the release of AA from hCG-stimulated Leydig cells, and under particular conditions, regulation of cAMP production by this fatty acid in these cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786377     DOI: 10.1677/joe.0.1720095

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  7 in total

1.  Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins.

Authors:  Dove J Keith; Amy J Eshleman; Aaron Janowsky
Journal:  Eur J Pharmacol       Date:  2010-10-20       Impact factor: 4.432

2.  Role of MMP-2 in PKCdelta-mediated inhibition of Na+ dependent Ca2+ uptake in microsomes of pulmonary smooth muscle: involvement of a pertussis toxin sensitive protein.

Authors:  Sajal Chakraborti; Amritlal Mandal; Sudip Das; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2005-12       Impact factor: 3.396

3.  Analysis of age-associated changes in mitochondrial free radical generation by rat testis.

Authors:  Martha E Vázquez-Memije; Ruth Capin; Adela Tolosa; Mohammed El-Hafidi
Journal:  Mol Cell Biochem       Date:  2007-09-06       Impact factor: 3.396

4.  Inhibition of thromboxane a synthase activity enhances steroidogenesis and steroidogenic acute regulatory gene expression in MA-10 mouse Leydig cells.

Authors:  Xingjia Wang; Xiangling Yin; Randolph B Schiffer; Steven R King; Douglas M Stocco; Paula Grammas
Journal:  Endocrinology       Date:  2007-11-15       Impact factor: 4.736

Review 5.  Leydig cells: From stem cells to aging.

Authors:  Haolin Chen; Ren-Shan Ge; Barry R Zirkin
Journal:  Mol Cell Endocrinol       Date:  2009-02-07       Impact factor: 4.102

6.  Peroxisome-proliferator-activated receptors and the control of levels of prostaglandin-endoperoxide synthase 2 by arachidonic acid in the bovine uterus.

Authors:  E Linda R Sheldrick; Kamila Derecka; Elaine Marshall; Evonne C Chin; Louise Hodges; D Claire Wathes; D Robert E Abayasekara; Anthony P F Flint
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

Review 7.  Stem cell therapy for the treatment of Leydig cell dysfunction in primary hypogonadism.

Authors:  Taylor C Peak; Nora M Haney; William Wang; Kenneth J DeLay; Wayne J Hellstrom
Journal:  World J Stem Cells       Date:  2016-10-26       Impact factor: 5.326

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.